When Diets Don’t Work: Parents Turn to Wegovy for Elementary School Kids

Parents of children as young as six are administering weight-loss medications—specifically GLP-1 drugs such as Wegovy—to address obesity concerns before traditional interventions like diet and exercise prove effective. Coverage highlights the growing trend as a response to rising childhood obesity rates, with some medical professionals raising questions about long-term safety and appropriateness for such young patients. Major outlets including *The Wall Street Journal*, *The Independent*, Yahoo, and AOL are reporting on the trend, framing it as a reflection of desperation among families struggling with pediatric obesity.

Discussions center on whether early medical intervention is justified or if it risks normalizing pharmaceutical solutions over lifestyle changes. Regulatory and ethical debates remain unresolved in most reports. Watch for potential updates on clinical guidelines, FDA statements, or long-term studies on GLP-1 drugs in pediatric populations.

Coverage may also expand to include parental testimonials or pediatrician perspectives on risk-benefit assessments.